MedTrace Logo

Added Value in Combined Use of Fusion Imaging and Contrast-enhanced Ultrasonography

NCT04487288 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2021-04-08

No results posted yet for this study

Summary

So far, there have been studies showing that the CEUS-grafted technique has added value in biopsy and RFA, but no studies have compared the group using only fusion and the group using CEUS+fusion. Therefore, the additional added value of CEUS will be evaluated by comparing the two groups.

Conditions

  • Contrast Media, Liver, Biopsy, Fusion

Interventions

DIAGNOSTIC_TEST

SONAZOID

CEUS using SONAZOID with fusion technique

Sponsors & Collaborators

  • Korean Liver Cancer Association

    collaborator UNKNOWN

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeong Min Lee, MD, PhD · Seoul National University Hospital, Radiology department

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-02
Primary Completion
2022-03-01
Completion
2022-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04487288 on ClinicalTrials.gov